Display Settings:

Format

Send to:

Choose Destination
    Scand J Rheumatol Suppl. 2004;119:19-23.

    Analgesic effects of 5-HT3 receptor antagonists.

    Source

    Max Planck Institute of Psychiatry, Munich, Germany.

    Abstract

    Current research suggests an involvement of 5-HT3 receptors in peripheral and central perception and processing of pain as well as in inflammation. Tropisetron and other selective 5-HT3 receptor antagonists have been used successfully for pain reduction and treatment of related symptoms in patients diagnosed with fibromyalgia. This article proposes a concept of the underlying pathophysiology and mechanisms of action of 5-HT3 receptor antagonists in the context of the relevant clinical data on their application in patients with rheumatic disease.

    PMID:
    15515407
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk